The GTTC is pleased to share its newest publication, “Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing,” published in Nature Reviews Drug Discovery. The commentary highlights the potential applications, advantages and challenges associated with ...
Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing
Nature Reviews Drug Discovery, 2023